Schedule 13G ownership disclosure
Apellis Pharmaceuticals Inc
Security class unavailable · CUSIP: 03753U106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,730,626
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-19-006570
- Form type
- SC 13G
- Filer
- Apellis Pharmaceuticals, Inc.
- CIK
- CIK 1492422
- Filed
- Feb 08, 2019
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership